[1]
Orsini, D. et al. 2025. Brodalumab efficacy in psoriasis patients with inadequate response to IL-23 or IL-12/23 inhibitors: multicenter Italian retrospective analysis - IL PSO (Italian Landscape Psoriasis). Dermatology Practical & Conceptual. 15, 4 (Oct. 2025), 6010. DOI:https://doi.org/10.5826/dpc.1504a6010.